This maintenance phase begins only after the initial deficiency has been corrected and the patients blood markers have stabilized within the normal range
Dosage can vary, but most protocols recommend daily injections for all three peptides
As of 2026, no Investigational New Drug (IND) application for BPC-157 has been filed with the FDA
After single IM administration at doses of 6, 30, or 150 g/kg, the T max values of each dose were 6.33, 8.67, and 8.17 min, respectively
Anthony Didato, DMD Managing Partner, Balanced Aesthetics + Wellness ARA-290 (Cibinetide) Innate Repair Receptor Agonist ARA-290 is an erythropoietin-derived peptide that activates the innate repair receptor without stimulating red blood cell production